national institute for clinical excellence
The British Association for Shooting and Conservation (BASC) has been granted permission by the High Court to bring a judicial review of Defra’s decision to withdraw the general licence (GL43) that allowed the release of gamebirds in certain areas of England. BASC’s ‘Fighting Fund’ is being used to support the High Court challenge. BASC chief executive Ian… Read more »
Long overdue legislation setting out the regulatory framework for physician assistants (PAs) and anaesthesia assistants (AAs) has been published today. Commenting on the legislation, Dr Michael Devlin, head of professional standards and liaison at the MDU said: “This important piece of legislation not only introduces much needed regulation for PAs and AAs, it will also be… Read more »
Latest articles
Cancer charities have today condemned the decision by the health watchdog not to make two bowel cancer drugs available on the NHS. The National Institute for Clinical Excellence (Nice) decided that bevacizumab (Avastin) and cetuximab (Erbitux), which cost £17,000 and £12,000 per patient respectively, were not cost effective given the other demands on the NHS… Read more »
Thousands of women will have access to a life-saving new drug on the NHS after the health watchdog today approved Herceptin for use against early stage breast cancer. The decision comes after a long-running battle between patients and primary care trusts (PCT) across the country, to tackle what was described as a “postcode lottery” in… Read more »
